Quantitative comparison of 2D and 3D late gadolinium enhancement MR imaging in patients with Fabry disease and hypertrophic cardiomyopathy
International journal of cardiology, 2016 - Elsevier
Background This study aims to determine whether the quantification of myocardial fibrosis in
patients with Fabry disease (FD) and hypertrophic cardiomyopathy (HCM) using a late …
patients with Fabry disease (FD) and hypertrophic cardiomyopathy (HCM) using a late …
Quantitative comparison of 2D and 3D late gadolinium enhancement MR imaging in patients with Fabry disease and hypertrophic cardiomyopathy
F Morsbach, S Gordic, C Gruner, M Niemann… - International Journal of …, 2016 - zora.uzh.ch
BACKGROUND: This study aims to determine whether the quantification of myocardial
fibrosis in patients with Fabry disease (FD) and hypertrophic cardiomyopathy (HCM) using a …
fibrosis in patients with Fabry disease (FD) and hypertrophic cardiomyopathy (HCM) using a …
Quantitative comparison of 2D and 3D late gadolinium enhancement MR imaging in patients with Fabry disease and hypertrophic cardiomyopathy
F Morsbach, S Gordic, C Gruner… - International …, 2016 - internationaljournalofcardiology.com
Background This study aims to determine whether the quantification of myocardial fibrosis in
patients with Fabry disease (FD) and hypertrophic cardiomyopathy (HCM) using a late …
patients with Fabry disease (FD) and hypertrophic cardiomyopathy (HCM) using a late …
Quantitative comparison of 2D and 3D late gadolinium enhancement MR imaging in patients with Fabry disease and hypertrophic cardiomyopathy
F Morsbach, S Gordic, C Gruner, M Niemann… - International Journal of …, 2016 - infona.pl
This study aims to determine whether the quantification of myocardial fibrosis in patients with
Fabry disease (FD) and hypertrophic cardiomyopathy (HCM) using a late gadolinium …
Fabry disease (FD) and hypertrophic cardiomyopathy (HCM) using a late gadolinium …
Quantitative comparison of 2D and 3D late gadolinium enhancement MR imaging in patients with Fabry disease and hypertrophic cardiomyopathy.
F Morsbach, S Gordic, C Gruner, M Niemann… - International journal of …, 2016 - sonar.ch
METHODS In this retrospective, IRB-approved study, 40 consecutive patients (18 male;
mean age 50±17years) with Fabry disease (n= 18) and HCM (n= 22) underwent MR …
mean age 50±17years) with Fabry disease (n= 18) and HCM (n= 22) underwent MR …
Quantitative comparison of 2D and 3D late gadolinium enhancement MR imaging in patients with Fabry disease and hypertrophic cardiomyopathy.
F Morsbach, S Gordic, C Gruner… - … Journal of Cardiology, 2016 - europepmc.org
Background This study aims to determine whether the quantification of myocardial fibrosis in
patients with Fabry disease (FD) and hypertrophic cardiomyopathy (HCM) using a late …
patients with Fabry disease (FD) and hypertrophic cardiomyopathy (HCM) using a late …
Quantitative comparison of 2D and 3D late gadolinium enhancement MR imaging in patients with Fabry disease and hypertrophic cardiomyopathy
F Morsbach, S Gordic, C Gruner… - International …, 2016 - pubmed.ncbi.nlm.nih.gov
Background This study aims to determine whether the quantification of myocardial fibrosis in
patients with Fabry disease (FD) and hypertrophic cardiomyopathy (HCM) using a late …
patients with Fabry disease (FD) and hypertrophic cardiomyopathy (HCM) using a late …
[引用][C] Quantitative comparison of 2D and 3D late gadolinium enhancement MR imaging in patients with Fabry disease and hypertrophic cardiomyopathy
F Morsbach, S Gordic, C Gruner… - International …, 2016 - research-collection.ethz.ch
Quantitative comparison of 2D and 3D late gadolinium enhancement MR imaging in
patients with Fabry disease and hypertrophic cardiomyopathy - Research Collection …
patients with Fabry disease and hypertrophic cardiomyopathy - Research Collection …